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ABSTRACT
DNA double-strand breaks enhance homologous
recombination in cells and have been exploited for
targeted genome editing through use of engineered
endonucleases. Here we report the creation and
initial characterization of a group of rare-cutting,
site-specific DNA nucleases produced by fusion of
the restriction enzyme FokI endonuclease domain
(FN) with the high-specificity DNA-binding domains
of AvrXa7 and PthXo1. AvrXa7 and PthXo1 are
members of the transcription activator-like (TAL)
effector family whose central repeat units dictate
target DNA recognition and can be modularly
constructed to create novel DNA specificity. The
hybrid FN-AvrXa7, AvrXa7-FN and PthXo1-FN
proteins retain both recognition specificity for their
target DNA (a 26bp sequence for AvrXa7 and 24bp
for PthXo1) and the double-stranded DNA cleaving
activity of FokI and, thus, are called TAL nucleases
(TALNs). With all three TALNs, DNA is cleaved
adjacent to the TAL-binding site under optimal
conditions in vitro. When expressed in yeast, the
TALNs promote DNA homologous recombination
of a LacZ gene containing paired AvrXa7 or asym-
metric AvrXa7/PthXo1 target sequences. Our results
demonstrate the feasibility of creating a tool box of
novel TALNs with potential for targeted genome
modification in organisms lacking facile mechan-
isms for targeted gene knockout and homologous
recombination.
INTRODUCTION
Perhaps the most signiﬁcant application of endonucleases
in the post genome era is their coupling with
custom-engineered proteins that recognize long stretches
of DNA sequences and their application for targeting
speciﬁc genes for knockout or gene replacement (1). The
key component of these engineered nucleases is the DNA
recognition domain that is capable of precisely directing
the nuclease to the target site for the purpose of
introducing a DNA double-strand break (DSB). These
breaks are principally repaired by one of two pathways,
non-homologous end-joining (NHEJ) or homologous
recombination (HR). Repair by NHEJ often results in
mutagenic deletions/insertions in the targeted gene.
Moreover, DSBs can stimulate HR between the endogen-
ous target gene locus and an exogenously introduced hom-
ologous DNA fragment with desired genetic information,
a process called gene replacement or genome editing (2–4).
To date the most promising method involving genome
editing is the use of custom-designed zinc ﬁnger nucleases
(ZFNs) (5). ZFN technology involves the use of hybrid
proteins derived from the DNA-binding domains of zinc
ﬁnger (ZF) proteins fused with the non-speciﬁc DNA-
cleavage domain of the endonuclease FokI (6,7).
FokI, a type IIS nuclease, was ﬁrst isolated from the
bacterium Flavobacterium okeanokoites (8). The nuclease
consists of two separate domains, an N-terminal DNA-
binding domain and a C-terminal DNA-cleavage
domain. The DNA-binding domain recognizes the
non-palindromic sequence 50-GGATG-30 while the cata-
lytic domain cleaves double-stranded DNA non-
speciﬁcally at a ﬁxed distance of 9 and 13 nucleotides
downstream of the recognition site (9,10). FokI exists as
an inactive monomer in solution and becomes an active
dimer upon binding to its target DNA and in the presence
of speciﬁc divalent metals (11). It has been proposed
that to form a functional complex, two molecules of
FokI each bind to their recognition sequence in a double
stranded DNA molecule and then dimerize in such a way
that the two nuclease domains unite to form a functional
endonuclease that cleaves both DNA strands at
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(12,13,14).
ZFNs can be assembled as modules that are custom-
designed to recognize selected DNA sequences, typically
18–24bp with a 4–7bp spacer between two half sites
(15–17). Following binding at the preselected site, a DSB
is produced by the action of the ZFN’s FokI cleavage
domain (4). ZFN technology has been successfully
applied to genetic modiﬁcation in a variety of organisms,
including yeast, plants, mammals and even human cell
lines [reviewed in (18,19)]. Despite the promise of ZFN
technology in basic and applied research, widespread
adoption of this technology has been hampered by a
bottleneck in custom-engineering zinc ﬁngers that
possess the requisite high speciﬁcity and afﬁnity for prese-
lected DNA target site. Such engineering is labor inten-
sive, time consuming and associated with high rates of
failure (20,21). Since the effectiveness of these endonucle-
ases depends almost solely on their DNA-binding speciﬁ-
city, the required speciﬁcity theoretically can be
supplanted by any high-ﬁdelity DNA-binding domain
when fused with a functional endonuclease domain. The
TAL effector proteins from a number of bacterial plant
pathogens represent a potential source of modularly con-
structed DNA-binding domains that could supply the
needed DNA-binding speciﬁcity.
TAL effectors belong to a large group of highly
conserved bacterial proteins that exist in various strains
of Xanthomonas sp. and are translocated into host cells by
a Type III secretion system and, thus, are called Type III
effectors [reviewed in (22)]. Once in host cells, some TAL
effectors have been found to transcriptionally activate
their corresponding host target genes either for strain viru-
lence (ability to cause disease) or avirulence (capacity to
trigger host resistance responses) dependent on the host
genetic context (23–26). Each of these bacterial effectors
contains a functional nuclear localization motif and a
potent transcription activation domain that are character-
istic of eukaryotic transcription activators. Each TAL
effector also contains a central repetitive region consisting
of varying numbers of repeat units of 34 amino acids (aa).
It is this repeat region that recognizes a speciﬁc DNA
sequence and determines the biological speciﬁcity of
each effector [Figure 1A, and reviewed in (27)]. Each
repeat is nearly identical except for two variable amino
acids at positions 12 and 13, the so called repeat
variable di-residues (RVD) (28). Recent studies have
revealed that the recognition of DNA sequences within
the promoter regions of speciﬁc host target genes is
deﬁned by the repeat regions of TAL effectors. The
DNA sequence recognition is based on a fairly simple
code where one nucleotide of the DNA target site is
recognized by the RVD of one repeat (i.e. one repeat/
one nucleotide recognition). The sequential tandem
array of repeats thus speciﬁes the DNA sequence that
will be bound (28,29). The majority of naturally occurring
TAL effectors contains repeat units in a range of 13–29
that presumably recognize DNA elements consisting of
the same number of nucleotides. Thus, in theory, the so
called TAL recognition code can be used as a guide for
custom-design of novel TAL effectors with the required
speciﬁcity to target a single locus in a genome.
AvrXa7 and PthXo1 are TAL Type III effectors from
Xanthomonas oryzae pv. oryzae (Xoo), the causal
pathogen of bacterial blight of rice. They each contain a
unique combination of RVDs in 26 and 24 repeats, re-
spectively (Figure 1B and C). For some Xoo strains,
AvrXa7 is a key virulence factor in susceptible rice. On
the other hand, it is also an avirulence determinant in the
otherwise resistant plants containing the cognate resist-
ance gene Xa7 (30,31). As the essential virulence factor,
AvrXa7 activates the rice gene Os11N3 to induce a state of
disease susceptibility (G.Anthony et al., manuscript in
preparation). The gene induction by AvrXa7 is mediated
through its recognition of a speciﬁc DNA element within
the promoter region of Os11N3, an element we refer to
here as the effector binding element (EBE) (sequence
shown in Figure 1B). Similarly, PthXo1 is also an essential
virulence factor for some strains of X. oryzae pv. oryzae
and activates the rice gene Os8N3 to promote bacterial
multiplication and disease development (24). PthXo1 rec-
ognizes an EBE of 24nt within the promoter of Os8N3
(32) (sequence shown in Figure 1C).
As a proof-of-principle, we have tested the feasibility of
generating a new type of DNA sequence-speciﬁc endo-
nuclease by utilizing the sequence speciﬁcities of AvrXa7
and PthXo1 and the catalytic activity of the endonuclease
FokI. Here we report the creation of TAL effector nucle-
ases (TALNs) by fusing the full-length AvrXa7 TAL
effector or the full-length PthXo1 TAL effector to the
FokI nuclease domain and the characterization of their
nuclease activities both in vitro and in vivo using a yeast
cell assay.
MATERIALS AND METHODS
Chimeric gene construction
Chimeric genes encoding fusions of TAL effector AvrXa7
or PthXo1 with the FokI nuclease (FN) domain at either
the N-terminus or the C-terminus (i.e. FN-AvrXa7,
AvrXa7-FN or PthXo1-FN) were constructed using
standard Escherichia coli strains and DNA techniques
(33). The full-length AvrXa7 was ﬁrst modiﬁed with
PCR primers Tal-F and Tal-R to integrate the restriction
sites KpnI and BglII upstream of the start codon at the
50-end and HindIII, XbaI and a stop codon containing
SpeI at the 30-end based on the plasmid pZWavrXa7
(30). AvrXa7 without its repetitive central region was
PCR ampliﬁed using primers Tal-F and Tal-R and
cloned into pBluescript KS using KpnI and SpeI. Then
the central repeat coding region was cloned back into
the plasmid lacking the central repeat element using
SphI, resulting in the plasmid pSK/AvrXa7. The SphI
fragment for central repeat domain of AvrXa7 in pSK/
AvrXa7 was replaced with that of PthXo1 from
pZWpthXo1 (24), resulting in the plasmid pSK/PthXo1.
The DNA fragment encoding the DNA-cleavage domain
(amino acids 388–583) of FokI (NCBI accession number
J04623) was PCR ampliﬁed using the primers Fokn-F1
and Fokn-R1 and a plasmid containing the FokI gene
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and BglII, while Fokn-R1 contained a BamHI restriction
site. The product was cloned into the A/T cloning vector
pGEM-T (Promega, Madison, WI, USA). The KpnI and
BamHI digested DNA fragment encoding FN was cloned
into KpnI and BglII treated pSK/avrXa7 resulting in
pSK/FN-AvrXa7 which contained the chimeric gene
with the FN coding region at its 50 and AvrXa7 at its
30-end. Similarly, FN coding sequence for C-terminal
fusion of AvrXa7 and PthXo1 was PCR ampliﬁed with
primers Fokn-F2 and Fokn-R2, which contain restriction
sites for HindIII and SpeI, respectively. The HindIII and
SpeI digested FN fragment was cloned into pSK/AvrXa7
and pSK/PthXo1 individually at their 30-ends. The
accuracy of all PCR products was conﬁrmed by
sequencing. Primer sequences are provided in the
Supplementary Table S1.
Transient expression assay for DNA-binding
activity of FN-AvrXa7
A construct containing green ﬂuorescence protein (GFP)
reporter gene cloned downstream of Os11N3 promoter,
which contains the AvrXa7 EBE sequence was made as
follows. The coding region for the GFP gene in plasmid
pEGFP (Clontech Laboratories, Mountain View, CA,
USA) was PCR ampliﬁed using primers GFP-F and
GFP-R and cloned into pGEM-T for sequence conﬁrm-
ation. The GFP coding region with added restriction
sites was cloned downstream of the promoter region
containing the AvrXa7 EBE and upstream of the
Os11N3 terminator, resulting in pEBE-GFP. The GFP
expression cassette was then cloned into pCAMBIA1300
(CAMBIA) at KpnI and HindIII restriction sites. The
resulting construct was transformed into Agrobacterium
tumefaciens strain EHA105 to create a ‘reporter’
Agrobacterium strain. DNA encoding FN-AvrXa7 was
cloned downstream of the cauliﬂower mosaic virus
(CaMV) 35S promoter in a modiﬁed pCAMBIA1300
vector and mobilized into EHA105 to create an
‘effector’ Agrobacterium strain. The effector strain con-
taining AvrXa7 (lacking the FN domain) was similarly
constructed to serve as a positive control. The reporter
and the effector strains were co-inﬁltrated into Nicotiana
benthamiana leaves. The inoculated leaves were checked
for expression of GFP using a Leica M205 FA ﬂuorescent
stereomicroscope.
Figure 1. Schematics of TAL effectors AvrXa7 and PthXo1 as well as their fusions with FN. (A) A typical TAL effector contains a central region of
34 aa direct repeats (open boxes) and three nuclear localization motifs (NLS, black bars) as well as a transcription activation domain (AD, red solid
box) at the C-terminus. The representative 34 aa repeat is shown below with the variable amino acid residues at the positions 12 and 13 in red.
(B) and (C) AvrXa7 and PthXo1 contain central 26 and 24 tandem repeats (shown as boxes) of 34 aa residues, respectively. The repeats are highly
conserved, except for residues at positions 12 and 13 (asterisk, missing amino acid residue at position 13). The sequence recognition of AvrXa7 to
Os11N3 (and PthXo1 to Os8N3) is dictated by the order of the 34 aa repeat units that each contain at positions 12 and 13, a pair of amino acids that
exactly recognize one nucleotide at one position in the DNA sequence of the EBE of the Os11N3 gene. (D–F) Schematics of TAL effector fusion
proteins with FN domain at the N-terminus of AvrXa7 (D) or at the C-termini of AvrXa7 (E) and PthXo1 (F). (G) Transient activation by AvrXa7
and FN-AvrXa7 of the Os11N3 promoter (containing the AvrXa7 EBE) driving a GFP reporter gene (GFP-EBE). The plasmid containing the GFP
reporter gene was co-injected along with a plasmid containing a gene encoding the AvrXa7 or AvrXa7-FN driven by the CaMV 35S promoter
[or with a plasmid containing the 35S promoter but no AvrXa7 coding sequence (Control)]. The dotted line indicates the edge of the inoculation site.
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The chimeric gene FN-AvrXa7 was cloned into pPROEX
HTb (Invitrogen, Carlsbad, CA, USA) by ligating the
BglII and SpeI digested FN-AvrXa7 fragment from
pSK/FN-AvrXa7 into the BamHI and SpeI digested ex-
pression vector. Similarly, the BglII and SpeI digested
AvrXa7-FN DNA fragment was cloned into pPROEX
HTb for AvrXa7-FN overexpression. For PthXo1-FN,
the expression vector pET28a (Novagen, Madison, WI,
USA) was used. The expression constructs were trans-
formed into E. coli strain BL21 (DE3) for overexpression
of the recombinant proteins with induction by isopropyl-
1-thio-b-D-galactopyranoside (IPTG) following the manu-
facturer’s instructions (Invitrogen). The 6Xhistidine
tagged FN-AvrXa7, AvrXa7-FN and PthXo1-FN were
puriﬁed with Ni-NTA agarose (Qiagen, Valencia, CA,
USA) and the protein concentrations were determined
using the BioRad Bradford protein quantiﬁcation kit
(BioRad, Hercules, CA, USA).
Electromobility shift assay
The complementary oligonucleotides of Os11N3-F &
Os11N3-R containing AvrXa7 EBE and Os11N3M-F &
Os11N3M-R containing a mutated AvrXa7 EBE were
annealed, respectively, and 50-end labeled with
[g-
32P]ATP catalyzed by T4 polynucleotide kinase. The
labeled oligonucleotide duplex DNA was mixed individu-
ally with AvrXa7-FN and FN-AvrXa7 in a 10ml reaction
volume containing Tris–HCl (15mM, pH 7.5), KCl
(40mM), DTT (1mM), glycerol (2.0%), poly(dI.dC)
(50ng/ul), EDTA (0.2mM),
32P-labeled DNA (ﬁnal con-
centration, 5fmol) and hybrid protein (ﬁnal concentra-
tion,  15fmol). Unlabeled oligonucleotides were used as
competitor probes and were added in increasing amounts
(ﬁnal concentration, 0–250fmol) to successive reactions.
The binding reactions were kept at room temperature
for 30min before loading onto a 6% TBE polyacrylamide
gel. After electrophoresis, the gel was exposed to X-ray
ﬁlm for radioactive image capture.
In vitro DNA cleavage
A 406bp genomic region of the rice Os11N3 gene encom-
passing the AvrXa7 EBE was PCR ampliﬁed with the
forward primer Os11N3P-F, and the reverse primer
Os11N3P-R, then cloned into the cloning vector pTOPO
(Invitrogen), resulting in pTOP/11N3. The plasmid was
also used to generate pTOP/Os11N3m2 using linker
scanning mutagenesis method with an insertion of 6nt
(50-cccggg-30) within the AvrXa7 EBE site. A DNA
fragment containing the dual EBEs for PthXo1 and
AvrXa7 in a tail-to-tail orientation (TD) was cloned into
pPCR Script Amp (Stratagene, Santa Clara, CA, USA),
resulting in the plasmid pEBE-TD. For pTOP/Os11N3
and pTOP/Os11N3m2 digestions, the sequenced clone
was digested to completion with EcoNI or MluI and
puriﬁed, 1mg of uncut plasmid or the digested DNA was
incubated individually with FN-AvrXa7 (225ng or other-
wise indicated in the text) and AvrXa7-FN (200ng) in a
volume of 15ml. The buffer condition was the same as
used for the electromobility shift (EMS) assay described
earlier, but in the presence of 2.5mM MgCl2.
In vitro digestions of pEBE-TD with TALNs
AvrXa7-FN and PthXo1-FN were performed differently.
Assays for TALN activities with or without post-digestion
with restriction enzyme BglI were conducted in vitro using
1mg of pEBE-TD supercoiled plasmid DNA in a 30ml
reaction volume containing Tris–HCl (20mM), pH 8.5,
NaCl (150mM), MgCl2 (2mM), glycerol (5%), BSA
(0.5mg/ml), DTT (1mM) and 5mgo fN i
+-afﬁnity
column-puriﬁed PthXo1-FN and/or AvrXa7-FN
incubated for 30min at 37 C. For reactions in which
BglI was used after TALN digestion, 10U of BglI were
added and digestion continued for an additional 20min.
For reactions in which both PthXo1-FN and AvrXa7-FN
were used simultaneously, the reaction conditions were
identical except that only 1mg of each TALN was
employed.
Yeast HR assay
The yeast strains YPH499 (MATa ura3-52 lys2-801_amber
ade2-101_ochre trp1-D63 his3-D200 leu2-D1) and YPH500
(MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-D63
his3-D200 leu2-D1) as well as expression vectors
(pCP3, pCP4 and pCP5) were described and kindly
provided by Dr Dan Voytas (34). The pCP5 derived
reporter construct containing a single AvrXa7 EBE was
made by inserting the annealed oligonucleotides (EBES-F
and EBES-R) into the BglII- and SpeI-digested pCP5. A
set of duplexes of oligonucleotides (x7-HDn1-F and
x7-HDn1-R, n1=6, 10, 14, 19, 24, 30, 35 and 40bp) con-
taining the dual AvrXa7 EBEs in a head-to-head (corres-
ponding to FN domain to FN domain of FN-AvrXa7)
orientation separated by a serial of spacers (n1) were
cloned into the BglII and SpeI digested pCP5 plasmid.
Similar constructs with two AvrXa7 EBEs in a TD and
separated by various lengths (2, 5, 8 and 19bp) of spacers
were also made using duplexes of oligonucleotides
(x7-TDn2-F and x7-TDn2-R, n2=2, 5, 8 and 19bp).
For the 19bp spacer conﬁguration, an additional one
reporter construct with a mutation in one AvrXa7 EBE
and another with a mutation in each of the AvrXa7 EBEs
were made. A third set of dual asymmetric EBEs with one
corresponding to AvrXa7 and the other to PthXo1 in a
TD were also cloned into pCP5 using PstI and SpeI. The
duplexes of oligonucleotides are x7/o1-TDn3, n3=6, 11,
16, 21, 26, 31 and 36bp. The expression vectors pCP3 and
pCP4 were ﬁrst modiﬁed with a linker sequence containing
multiple cloning sites (MCSs) downstream of the transla-
tion elongation factor 1a (TEF1) promoter, resulting
in pCP3M and pCP4M, respectively. The linker was
made by annealing two oligonucleotides (Linker-F and
Linker-R) and cloned into the XbaI and XhoI digested
pCP3 and pCP4 individually. The chimeric genes
FN-AvrXa7 and AvrXa7-FN were digested with BglII
and SpeI and cloned into the BamHI and SpeI digested
pCP3M vector, while the chimeric gene PthXo1-FN was
cloned into pCP4M by BglII and SpeI. The reporter
plasmids each were transformed into the yeast mating
362 Nucleic Acids Research, 2011,Vol. 39,No. 1strain YPH500 (MAT-a) and effector plasmids in a
combination of pCP3M-FN-AvrXa7/pCP4M, pCP3M-
AvrXa7-FN/pCP4M and pCP3M-AvrXa7-FN/pCP4M-
PthXo1-FN into YPH499 (MATa). Yeast cells from a
single yeast colony carrying the reporter plasmid with
little b-galactosidase background was mixed with cells
from single colony with the effector plasmid (in a combin-
ation indicated in text) in triplicate on yeast nutrient
medium (YPD) overnight, then cultured in synthetic
complete medium lacking leucine, histidine and trypto-
phan to select for mated cells. The cells were then
harvested for quantitative measurement of b-galactosidase
activity by using the yeast b-galactosidase assay kit
from Thermo Fisher Scientiﬁc (Rockford, IL, USA) fol-
lowing the manufacture’s manual. Enzyme activity is
calculated based on the equation: b-galactosidase
activity=(1000 A420)/(t V OD660), t=time of incu-
bation in minutes, V=volume of cells used in the
assay in ml.
As a positive control to our yeast assay for TALN
activity, we also constructed an effector plasmid contain-
ing a ZFN and a reporter plasmid containing the corres-
ponding ZF-binding site. A DNA fragment encoding the
‘original’ BCR-ABL three-ﬁnger array was obtained by
the digestion of pGP-FB-orig BA (35) with XbaI and
BamHI and cloned into pCP3, resulting in a translational
fusion of BCR-ABL with a C-terminal FokI nuclease
domain. The oligonucleotide duplex containing the dual
ZFN target sites in a TD separated by a 6bp spacer
was cloned into pCP5 by BglII and SpeI, resulting in
the reporter plasmid. The effector plasmid pCP4-ZFN
and pCP3M were transformed into YPH499. The
transformants were mated with YPH500 containing the
reporter plasmid pzf-TD6 and measured for
b-galactosidase activity as described earlier for TALNs.
Sequence information for oligonucleotide duplexes
employed is provided in Supplementary Figure S4.
RESULTS
Construction of the chimeric genes for FN-AvrXa7,
PthXo1-FN and PthXo1-FN
AvrXa7 and PthXo1 are two naturally occurring TAL
effectors containing a central region of 26 and 24 repeat
units, respectively, with, like their relatives, the last repeat
containing only the ﬁrst 20 aa residues similar to other
repeats. The speciﬁc arrays of 26 RVDs in AvrXa7 and
24 RVDs in PthXo1 make the target sequences of AvrXa7
and PthoXo1 unique in comparison with all other TAL
effectors [Figure 1B and C; (26)]. AvrXa7 binds to a
speciﬁc 26bp promoter element, EBE, in the rice
Os11N3 gene through its DNA-binding repeats
[Figure 1B; (32); and G.Anthony et al., manuscript in
preparation], while PthXo1 binds to a speciﬁc 24bp
sequence in the promoter region of Os8N3 (24). The nu-
cleotide ‘T’ that precedes all known TAL effector target
sites and is essential for the target gene activation (28,29)
is also present immediately upstream of the ﬁrst nucleotide
of EBEs of Os8N3 and Os11N3 and, therefore, is treated
as part of EBE throughout this article. We reasoned that a
chimeric protein composed of AvrXa7 or PthXo1 and a
DNA cleavage domain of an endonuclease might function
in recognizing the Os11N3 and Os8N3 target sequences,
respectively, and cleaving DNA adjacent to the recogni-
tion site. The DNA-cleavage domain of the endonuclease
FokI was chosen due to its well-documented non-speciﬁc
catalytic activity when linked with other DNA-binding
domains, such as zinc ﬁnger proteins. Reﬂecting the con-
ﬁguration of the chimeric protein we designed, FN-
AvrXa7 was constructed by fusing the DNA sequence
encoding the full-length AvrXa7 TAL effector down-
stream of the DNA sequence encoding the cleavage
domain of FokI. AvrXa7 and PthXo1 constructs were
also made that each express hybrid proteins with the FN
domain at the C-terminus of each TAL effector. The
resulting chimeric genes were predicted to encode
proteins of 1645, 1648 and 1574 aa residues, respectively
(Figure 1D–F). The 196 aa FokI domain is linked by 4 aa
residues to the 1459 aa of AvrXa7 in FN-AvrXa7 and by
2 aa in both AvrXa7-FN and PthXo1-FN (also see
Supplementary Figure S1 for the complete nucleotide
and amino acid sequences of FN-AvrXa7, AvrXa7-FN
and PthXo1-FN).
Transcription enhancement by FN-AvrXa7 in vivo
In addition to a DNA-binding domain, the TAL effectors
contain a potent C-terminal transcription activation
domain (27). Thus, we reasoned that by placing the
FokI nuclease domain at the N-terminus of TAL effectors,
the activation domain would remain functional. We could
then take advantage of transcription enhancement as an
indirect measure of the DNA-binding ability of the hybrid
protein, FN-AvrXa7 in this case, or of any newly
synthesized TAL fusion protein, in general.
We adapted a modiﬁed A. tumefaciens mediated tran-
sient expression assay that has been successfully used for
studying the interaction of TAL effectors with their
target host genes (26,29). In our case, the ‘reporter’ con-
struct contained the gene encoding a GFP under the
control of the Os11N3 promoter that contains the
AvrXa7 EBE. Two ‘effector’ constructs were made to
express either AvrXa7 or FN-AvrXa7 under control of
the strong and constitutive CaMV 35S promoter. Both
reporter and effector genes were delivered by injection of
Nicotiana benthamiana leaves with A. tumefaciens to
allow co-expression of genes from the effector and
reporter constructs. Both AvrXa7- and FN-AvrXa7-
containing constructs induced the expression of GFP
while the construct lacking either AvrXa7 or FN-
AvrXa7 did not (Figure 1G). These results indicated
that the hybrid FN-AvrXa7 retained the DNA-binding
ability of AvrXa7, and that the transient expression
assay could provide a means to test the DNA-binding
ability or speciﬁcity of TAL-derived hybrid proteins
in vivo.
Overexpression and puriﬁcation of FN-AvrXa7,
AvrXa7-FN and PthXo1-FN
The FN-AvrXa7 and AvrXa7-FN were each cloned into
an overexpression vector in frame with an N-terminal
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ﬁcation on a Ni-containing column after overproduction
of the TAL hybrid protein in E. coli. The proteins were
successfully isolated in a relatively high purity
(Supplementary Figure S2). The identity of FN-AvrXa7
and AvrXa7-FN were further conﬁrmed with protein blot
analysis using an antibody against the FLAG epitope that
was integrated after the repeat regions of AvrXa7 and
PthXo1 (Supplementary Figure S2B and C). The
FLAG-tagged proteins detected were  175 KDa, the
calculated sizes of FN-AvrXa7 and AvrXa7-FN, respect-
ively. IPTG-induced E. coli cells overexpressing
FN-AvrXa7 or AvrXa7-FN did not exhibit any obvious
growth defects (data not shown). Overexpression and
puriﬁcation of PthXo1-FN were achieved in a similar
fashion to that for FN-AvrXa7 and AvrXa7-FN.
DNA-binding activities of AvrXa7-FN and FN-AvrXa7
in vitro
AvrXa7-FN and FN-AvrXa7 puriﬁed from E. coli were
tested for their DNA-binding speciﬁcities in vitro. The
abilities of puriﬁed AvrXa7-FN and FN-AvrXa7 to bind
DNA targets in vitro were investigated using
double-stranded oligonucleotides containing the AvrXa7
EBE of Os11N3 or its mutated version, Os11N3M, con-
taining 5nt substitutions near the 50-end of its EBE
sequence (Figure 2A). The binding reactions were
carried out in the solution lacking divalent metal cations
such as Mg
2+ to prevent cleavage of the oligonucleotides
(‘Materials and Methods’ section). The EMS assay
demonstrated that AvrXa7-FN and FN-AvrXa7 preferen-
tially bound to the labeled double stranded DNA contain-
ing the authentic AvrXa7 EBE target sequence but did not
effectively bind to the probe containing the mutated target
sequence containing ﬁve nucleotide changes near the
50-end of the EBE (Figure 2B, left panels). Furthermore,
AvrXa7-FN and FN-AvrXa7 binding to the
32P-labeled
AvrXa7 EBE could be competed away using increasing
amounts of unlabeled DNA nucleotides of the same
sequence (Figure 2B, middle panels). However, the
binding to the labeled Os11N3 was not competed away
with an excess of the variant oligonucleotide, Os11N3M
(Figure 2B, right panels).
DNA cleavage activities of FN-AvrXa7, AvrXa7-FN
and PthXo1-FN in vitro
We also tested the abilities of FN-AvrXa7, AvrXa7-FN
and PthXo1-FN to cleave substrate DNA individually or
in combination in vitro. For experiments with individual
FN-AvrXa7 and AvrXa7-FN TALNs, we chose a plasmid
containing a cloned DNA fragment of the Os11N3
promoter from rice. The plasmid pTOP/Os11N3 was
ﬁrst linearized at a unique restriction site (EcoNI) or
digested with MluI (Figure 3A and B, lanes 2 and 3).
The DNA was then incubated with FN-AvrXa7 or
AvrXa7-FN at 37 C for 1h using the EMS assay buffer
with the addition of 2.5mM MgCl2. The FN-AvrXa7
and AvrXa7-FN each cleaved the EcoNI-linearized
pTOP/Os11N3 plasmid into two fragments of the
expected size (0.8 and 2.1kb) (Figure 3B, lanes 5 and 8).
Incubation of the supercoiled pTOP/11N3 (Figure 3B,
lane 1) with an appropriate amount of FN-AvrXa7 or
AvrXa7-FN resulted in partial linearization of the
plasmid (Figure 3B, lanes 4 and 7, respectively).
Individual FN-AvrXa7 and AvrXa7-FN also cleaved the
MluI predigested pTOP/11N3 into an expected pattern of
DNA fragments (Figure 3B, lanes 6 and 9, respectively).
Taken together, the results indicate that both FN-AvrXa7
and AvrXa7-FN mediated-cleavages occur at the AvrXa7
EBE site.
To investigate the speciﬁcity of cleaving action by
FN-AvrXa7 in more detail, a plasmid containing a
mutated binding site of AvrXa7 was generated from
pTOP/Os11N3 using a linker scanning mutagenesis
method to contain a 6bp insertion immediately down-
stream of the initial ‘T’ residue of the Os11N3 EBE
(Supplementary Figure S3A). This EBE mutation abol-
ished the ability of AvrXa7 to elicit GFP gene expression
when placed in the Os11N3 promoter in our Os11N3
promoter assay (data not shown), which is consistent
with the ﬁnding that the ‘T’ immediately upstream of
the ﬁrst EBE nucleotide is essential for the TAL effector
mediated activation of target genes (29). Incubation
of the same amount (1mg) of EcoNI pretreated DNA of
pTOP/Os11N3, the mutant pTOP/Os11N3m2 and pTOP/
GFP (a plasmid containing a GFP gene sequence unre-
lated to the AvrXa7 EBE) with an appropriate amount
of FN-AvrXa7 resulted in digestion of pTOP/Os11N3,
Os11N3  GCACTATATAAACCCCCTCCAACCAGGTGCTAAGC
Os11N3M GCACTtTtTtttCCCCCTCCAACCAGGTGCTAAGC
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Figure 2. Binding speciﬁcity of AvrXa7-FN and FN-AvrXa7 fusion
proteins to their target DNA. (A) Sense-strand sequences of the wild
type (Os11N3) and mutant (Os11N3M) oligonucleotide duplexes used
in the EMS assays. (B) EMS assays demonstrating speciﬁcities of
AvrXa7-FN and FN-AvrXa7 binding to the AvrXa7 EBE sequence.
The set of gel images to the left depict results with AvrXa7-FN, while
set of gel images to the right depict results with FN-AvrXa7. The left
panels of each set show binding of AvrXa7-FN and FN-AvrXa7 to the
authentic,
32P-labeled, Os11N3 DNA target element but not to the
mutated target. Competition assays (middle and right panels of each
set) showing that the binding of
32P-labeled Os11N3 EBE target by
AvrXa7-FN and FN-AvrXa7 is effectively competed by excess
amounts of non-radioactive Os11N3 oligonucleotides (middle panels
of each set), but not by the non-radioactive mutated version of
Os11N3 DNA (right panels). Positions of the bound and free probes
are indicated at the left of the autoradiograph.
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(Supplementary Figure S3B). The speciﬁc and expected
cleavage pattern observed with digestion of pTOP/
Os11N3 DNA was not observed with the mutant pTOP/
Os11N3m2 even with increasing amounts of FN-AvrXa7
protein (Supplementary Figure S3C). These experiments
demonstrate that the FN-AvrXa7 is a highly selective
endonuclease, having the ability to cleave double
stranded DNA while discerning the preferred target site
from a slight variant or unrelated DNA sequence.
Additional evidence for speciﬁc cleavage by TALNs in
close proximity to EBE sites has come from cleavage
patterns of DNA sequences that are targets for
PthXo1-FN as well as AvrXa7-FN and PthXo1-FN in
combination. Cleavages of the EBE site (Figure 3C) of
plasmid pEBE-TD (Figure 3D) with either of the two
TALNs (or EcoRI) cause linearization (or partial linear-
ization) of the plasmid to produce a band of 3052bp
(Figure 3E, lanes 2, 4 and 6). To deﬁne the site of
TALN-mediated DNA cleavage, post treatment of
TALN-digested plasmid DNA with BglI was employed.
BglI alone produces DNA fragments of 1786 and
1266bp (Figure 3E, lane 3). Incubation with
AvrXa7-FN alone results in incomplete digestion of the
supercoiled plasmid and produces a band of DNA
migrating at  3kb along with another band migrating
Figure 3. Target DNA digestion by the FN-AvrXa7, AvrXa7-FN and PthXo1-FN TALNs. (A) Circular plasmid containing a 400bp Os11N3
promoter region (thick bar in red) with one AvrXa7 EBE site (position 0). EcoNI cuts once at position 842 and MluI cuts twice at positions 1405 and
2246 relative to EBE of the plasmid. The expected sizes of fragments after cleavages are shown below the plasmid map. (B) Gel image of plasmid
DNA treated with different enzymes individually or in combinations. M, 1kb markers with size labeled on the left side. Different treatments are
indicated above lanes 1–9 and in combination with TALNs labeled below lanes 4–9. Arrows in red indicate DNA fragment sizes expected if the
NF-AvrXa7 or AvrXa7-FN nuclease cleavage takes place correctly at the AvrXa7 EBE target site in pTOP/Os11N3. (C) Structure of adjacent
PthXo1 and AvrXa7 EBE sites (underlined) in a TD (to allow FN to FN proximity) and separated by 19 spacer nucleotides (lower case letters) which
contains a unique EcoRI site (underlined). (D) Map of plasmid pEBE-DT with predicted cleavage sites for EcoRI (position 0), PthXo1-FN and/or
AvrXa7-FN EBEs and BglI (positions 1479 and 2745). (E) Gel image of intact pEBE-DT (lane 1), EcoRI–linearized plasmid (2), BglI-cleaved
plasmid (3), AvrXa7-FN digested plasmid DNA (4), AvrXa7-FN digested plasmid followed by BglI digestion (5), PthXo1-FN digested plasmid (6),
PthXo1-FN digested plasmid followed by BglI digestion (7) and double digestion with PthXo1-FN and AvrXa7-FN (at one-ﬁfth the concentrations
of each protein used individually in reactions for lanes 3 to 6) followed by BglI digestion (8). The label ‘M’ indicates the DNA marker lane with
marker sizes provided in kilo-base (kb). Arrows to the right indicate sizes of DNA fragments expected from complete DNA digestion with BglI and
partial digestion with PthXo1-FN (lane 5), AvrXa7-FN (lane 7) or PthXo1-FN combined with AvrXa7-FN (lane 8).
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BglI is added to the digestion mix 30min after cutting with
AvrXa7-FN has begun, four DNA fragments are observed
that correspond to sizes interpreted to be 1786, 1479, 1266
and 307bp (Figure 3E, lane 5). This pattern is fully com-
patible with the interpretation that the initial cutting by
AvrXa7-FN was at the EBE target site, but was only par-
tially complete. Post incubation with BglI resulted in two
BglI-BglI DNA fragments of 1786 and 1266bp and two
AvrXa7-FN-BglI bands of 1479 and 307bp. When
pEBE-TD is incubated with PthXo1-FN three DNA frag-
ments are observed (Figure 3E, lane 6), a weak band
co-migrating with uncut supercoiled plasmid, a band
co-migrating with linearized DNA and a band >10kb.
When BglI is subsequently added to the reaction, again
four bands of DNA are observed (Figure 3E, lane 7).
Double digestion of pEBE-TD with AvrXa7-FN and
PthXo1-FN using only one-ﬁfth the amount of each
TALN used in the reactions whose products are displayed
in lanes 4 through 7, results once more in the appearance
of four bands, but with somewhat greater representation
of bands of molecular sizes of 1479, 1266 and 307bp—and
signiﬁcantly less non-speciﬁc DNA cleavage (compare
lanes 5 and 7 with lane 8). The possible nature of the
DNA band migrating with an apparent molecular size
>10kb is considered in the ‘Discussion’ section below.
To further identify the major cleavage sites of the sense
and antisense strand, the cleaved DNA fragments
(expected sizes of  840 and 2120bp) derived from
pTOP/Os11N3 treated independently with AvrXa7-FN
and FN-AvrXa7 were puriﬁed and subjected to
sequencing. Each band was expected to contain part of
the Os11N3 promoter fragment, but it was unclear
which contained the actual target site. Primers that ﬂank
the original 0.4kb Os11N3 promoter fragment were
chosen to sequence each of the digested plasmid bands.
These primers presumably were able to sequence through
the entire EBE site if it was present. For AvrXa7-FN
cleavage, the right side primer (M13R on pTOPO) was
used to sequence the sense strand of the 0.8kb fragment,
while M13F was used to sequence the antisense strand of
the 2.1kb fragment (Figure 4A). The reverse complemen-
tary DNA sequencing trace (Figure 4A, the upper chro-
matograph) from the sense strand of the 0.8kb fragment
ends 2bp downstream of the last EBE nucleotide. On the
other hand, the sequence from the antisense strand of
2.1kb fragment ends 17bp downstream of last EBE nu-
cleotide (Figure 4A, lower chromatograph), resulting in a
15bp cutting ‘zone’ of each DNA fragment. These results
indicate that the major cleavages of double stranded DNA
by the action of AvrXa7-FN occur downstream of the
EBE site, a ﬁnding that is consistent with the expected
Figure 4. DNA sequencing revealing the major cleavage sites created by the AvrXa7-FN (A) and FN-AvrXa7 (B). (A) DNA sequencing chromato-
gram above the original Os11N3 dsDNA sequence (sense strand colored for ease of viewing) is based on the sense strand of the 0.8kb fragment
puriﬁed from lane 8 in Figure 3B. The M13R primer was used for sequencing the sense strand. The chromatogram, which represents the sense strand
sequence around the cleavage site, is in reverse-complement orientation for ease of viewing. The chromatogram below the dsDNA sequence is derived
from the antisense strand of the 2.1kb DNA fragment (also from lane 8 in Figure 3B) to the left of the predicted AvrXa7-FN cleavage site. The
AvrXa7-FN binding site is boxed in shaded gray. The vertical arrows denote the obvious cleavage sites in both strands. The thick underline indicates
the 15bp region downstream of the EBE site in which the vast majority of AvrXa7-FN cleavage occurred. (B) DNA sequencing chromatograms
of two DNA fragments derived from pTOP/11N3 treated with FN-AvrXa7 and puriﬁed from lane 5 in Figure 3B. Labeling is similar to that
used for (A).
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binding domain given the conﬁguration of the two com-
ponents. For FN-AvrXa7 cleavage (Figure 4B), the
sequence trace from the antisense strand of the 1.2kb
fragment ends 14bp upstream of the ﬁrst nucleotide of
the EBE (Figure 4B, lower chromatograph), while the
sequencing trace (reverse complementary to the original
trace) generated from the sense strand of the 0.8kb
fragment terminated completely after the sixth nucleotide
upstream of the last nucleotide of the EBE sequence
(Figure 4B, upper chromatograph), but within the EBE
site. These latter cutting sites were unexpected given the
position of the FN domain relative to the FN-AvrXa7
DNA-binding site and the presumed protection of the
site by the AvrXa7 binding. Repeated sequencing of
DNA fragments from additional experiments yielded
similar results and, thus, provide no explanation for the
observed, but unexpected, DNA-cleavage pattern with
FN-AvrXa7.
Stimulated HR in yeast by FN-AvrXa7, AvrXa7-FN and
AvrXa7-FN/PthXo1-FN
We sought to test the ability of the TALNs to bind and
cleave target sequences in vivo by using a previously estab-
lished yeast single-strand annealing (SSA) assay (34,36).
In this assay, a ‘reporter’ construct is coexpressed with an
‘effector’ construct in yeast cells. The reporter construct
contains a divided LacZ gene in which a duplicated 125bp
portion of the LacZ coding region has been created. The
direct repeat within the LacZ gene is separated by a 1.2kb
sequence containing the URA3 gene (Figure 5A) or a
shorter 0.2kb sequence (Figure 5B) and a MCS. It is
expected that the direct DNA repeats will undergo HR
at high efﬁciency when a DSB is created between the
repeats, resulting in a reconstituted and functional LacZ
gene. Measurement of b-galactosidase (LacZ product) en-
zymatic activity was used to quantify the recombination
frequency that, in turn, reﬂects the activity of TALNs in
the presence of various target sequences (37–39).
For TALN assays, the Saccharomyces cerevisiae
YHP500 strain carrying the reporter plasmid with only a
single EBE of AvrXa7 EBE (x7-S) was mated with
YHP499 harboring pCP3M-FN-AvrXa7/pCP4M or
pCP3M-AvrXa7-FN/pCP4M (Figure 5). Cells carrying
the reporter and effector plasmids in either combination
did not show increased b-galactosidase activity compared
with control cells transformed with two effector plasmids
lacking any TALN (data not shown). The results sug-
gested that a single EBE site was insufﬁcient for TALNs
FN-AvrXa7 or AvrXa7-FN to effectively cleave double
stranded DNA at the target site or at any nearby site
within the reporter plasmid in vivo. The results also sug-
gested a possible requirement for binding of two TALNs
in an orientation allowing efﬁcient dimerization of their
FokI nuclease domains—in a fashion similar to that
needed for successful DNA cleavage by ZFNs. We, there-
fore, reasoned that two TAL EBE sites in a proper orien-
tation and with an appropriate spacing could bring the
FokI nuclease domains in sufﬁciently close vicinity to
dimerize and consequentially execute a double strand
cleavage. To test the hypothesis, we designed two con-
structs, one with two identical AvrXa7 EBE sites located
in a head-to-head orientation (HD) for FN-AvrXa7 and
the other in a TD for AvrXa7-FN. Another construct was
made containing two EBE sites, one for AvrXa7 and one
for PthXo1, appropriately situated to allow tail-to-tail
(TD; FN to FN) interaction between EBE-bound
AvrXa7-FN and PthXo1-FN. We also sought to deter-
mine the optimal range of spacer lengths between the
two EBE sites in each conﬁguration to allow for efﬁcient
TALN cleavage (Figures 5A and B, Supplementary
Figure S4). For FN-AvrXa7, the head-to-head oriented
dual EBE sites (HD) were separated by a series of
spacers of 6, 14, 19, 24, 30, 35 and 40bp in length
(Figure 5A, DNA sequences provided in Supplementary
Figure 4SC). Each reporter plasmid was coexpressed with
pCP3M-FN-AvrXa7. Yeast cells containing constructs
with spacers of 30 nucleotides or more exhibited
b-galactosidase activities that increased with the length
of the spacer element employed (Figure 5C).
To compare the cleavage efﬁciency of the TALNs con-
taining a C-terminal FN (using a TD of dual target sites)
with efﬁciency obtained with a known ZFN under the
similar context, we performed an assay with a ZFN con-
sisting of the ‘original’ BCR-ABL three-ﬁnger array and
the FokI nuclease domain (35). For this experiment,
YHP499 cells expressing BCR-ABL-FN were mated
with YHP500 cells containing the reporter plasmid
pzf-TD6 that contained a dual tail-to-tail target site for
the BCR-ABL three-ﬁnger domain. As expected, the
diploid cells exhibited high b-galactosidase enzymatic
activity compared to cells lacking the effector plasmid
(Figure 5D). For experiments with AvrXa7-FN, the
tail-to-tail dual EBE sites were separated by spacers
of 2, 5, 8 and 19bp (Figure 5A, Supplementary
Figure S4D). Among this collection of reporter
plasmids, only the plasmid containing the 19bp spacer
produced increased b-galactosidase in yeast cells when
coexpressed with AvrXa7-FN. The magnitude of
response was directly comparable to that obtained with
the ZFN (Figure 5D). Only background levels of
b-galactosidase expression were obtained when
FN-AvrXa7 was substituted for AvrXa7-FN (data not
shown). Furthermore, no stimulation of b-galactosidase
activity was observed in cells expressing AvrXa7-FN if
either one or both AvrXa7 EBEs was mutated
(Figure 5D). We further tested the ability of two different
species of TALNs, AvrXa7-FN and PthXo1-FN, to act in
concert to recognize and cleave an asymmetric target
sequence separated by a serial spacer (x7/o1-TDn3,
n3=6, 11, 16, 21, 26, 31 and 36bp) (Figure 5B; also see
sequences in Supplementary Figure S4E). The yeast cells
containing reporter plasmids each with spacer in length of
16, 21, 26 or 31 exhibited signiﬁcantly increased
b-galactosidase activity in the presence of AvrXa7-FN
and PthXo1-FN together (Figure 5D). Taken together,
these results suggest requirements for dual EBE target
sites, optimized spacer lengths between the EBEs as well
as dimerization of TALN FN domains for efﬁcient
cleavage of double stranded DNA target sites by
TALNs in living yeast cells.
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Many years of effort spent in elucidating the interaction
between TAL effectors and their modulated host genes
has led to a recent breakthrough in deciphering the
DNA recognition code of TAL effectors (28,29). The pre-
dictability and potential manipulability of the TAL central
repeat domain for DNA-binding speciﬁcities make TAL
an excellent system for exploiting potential biotechno-
logical applications. In the present study, we created
chimeric TALNs, FN-AvrXa7, AvrXa7-FN and
PthXo1-FN containing the entire AvrXa7 or PthXo1
TAL effectors and the nuclease domain of the FokI re-
striction enzyme either at the C-terminal end or the
N-terminal end of each TAL effector. All three constructs
were tested for the ability to bind to the respective EBE
recognition site and to cleave adjacent DNA. Binding of
FN-AvrXa7 to the AvrXa7 EBE in vivo was demonstrated
by its ability to activate transcription of a GFP coding
sequence driven by the rice Os11N3 promoter that
contains the AvrXa7 EBE binding site (Figure 1G). All
three TALNs were successfully overproduced and puriﬁed
from E. coli cells (AvrXa7 TALNs, Supplementary
Figure S2). FN-AvrXa7 and AvrXa7-FN each were
shown to bind speciﬁcally to double-stranded oligonucleo-
tides containing the AvrXa7 EBE target site, but not to a
slightly modiﬁed version of the binding site in an EMS
assay (Figure 2). Moreover, the puriﬁed AvrXa7-FN
and FN-AvrXa7 TALNs exhibited cleavage activity near
the expected EBE binding site under optimized reaction
conditions in an in vitro assay, the results of which were
A
C
D
B
Figure 5. Yeast SSA assay for detection of FN-AvrXa7, AvrXa7-FN and PthXo1-FN TALN-induced HR. (A) Schematics of the reporter constructs
(not drawn to scale) with dual BCR-ABL target site, AvrXa7 EBE site in different conﬁgurations drawn below. Two non-functional LacZ gene
fragments (LacZn and LacZc, blue solid bars) were separated by the yeast URA3 gene (gray line) and a MCS (black line). The 125bp duplicated
LacZ coding sequences are represented as hatched blue boxes. The target sites in the reporter constructs are designated as zf-TD6 (ZFN dual sites),
x7-S (single EBE site), x7-DHn1 (dual AvrXa7 EBEs in a HD separated by the red-lined spacers), x7-TDn2 (dual tail-to-tail AvrXa7 EBEs) followed
by the number of spacer nucleotides. The constructs x7-TD19m1 and x7-TD19m2 contain a 19bp spacer and carry a mutation in their EBE site
caused by a 4bp substitution (depicted as a red cross). (B) Schematics similar to (A) with a 125bp fragment (gray line) instead of the URA3 gene
between the MCS and LacZn.( C) Activity of FN-AvrXa7 on reporters with different lengths of spacer between the AvrXa7 EBE sites (respective
spacer lengths are given below each column). Fold change represents the b-galactosidase activity of yeast cells co-expressing the respective reporter
and FN-AvrXa7 compared to cells containing the same reporter but lacking the FN-AvrXa7 expression vector. (D) Stimulation by the ZFN,
AvrXa7-FN and AvrXa7-FN/pthXo1-FN constructs of their respective reporter genes containing various spacers (lengths in base pairs given
below each column). Fold change represents the b-galactosidase activity of yeast cells co-expressing each reporter and its respective effector nucle-
ase(s) (indicated below the columns) compared to those containing the same reporter but lacking the presence of genes encoding the respective
nuclease(s). Error bars represent the standard deviation of three samples.
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Likewise, PthXo1-FN (alone and together with
AvrXa7-FN) was shown to speciﬁcally cleave at its
speciﬁc EBE DNA target site and produce the predicted
sized DNA fragments (Figure 3). Finally, expression of
the chimeric FN-AvrXa7, AvrXa7-FN and PthXo1-FN
TALNs in yeast stimulated HR between internal repeats
of a disrupted and non-functional reporter gene (LacZ)
that contained appropriately paired AvrXa7 or asymmet-
ric AvrXa7/PthXo1 target sites (Figures 5). These obser-
vations demonstrate the successful creation of functional
TALNs and lead the way to future experimentation
directed toward development of a technology for high-
speciﬁcity gene knockout and HR in organisms that
currently lack the ability to support either process in a
practical manner for laboratory research.
FokI and its fusion proteins with zinc ﬁnger
DNA-binding domains have been extensively studied.
The endonuclease domain (FN) by itself has no speciﬁcity
for cleavage, but cuts DNA at a set distance from the
binding site speciﬁed by the FokI DNA-binding domain
when the two domains are linked together (13–15). In this
sense, several types of FN based fusion proteins have been
successfully created that combine new DNA sequence
binding speciﬁcities with the FN cleavage activities, with
ZFNs being the most familiar (6,7,40). Study has shown
that fusion of FN to ZF motif does not change the
DNA-binding speciﬁcity of the ZF protein although it
may cause slight decrease in binding afﬁnity (41). We
chose the FokI cleavage domain to fuse with members
of the TAL effector family and, as a proof of principle,
demonstrated the feasibility and generality of creating a
new class of rare-cutting, site-speciﬁc DNA nucleases with
sequence speciﬁcities attributable to the TAL effectors.
The DNA-binding features of TAL effectors make this
group of proteins or their repetitive domains desirable as
the key component of such chimeric endonucleases for a
number of applications, including various sorts of genome
editing. For example, the majority of naturally occurring
TAL effector proteins contains a large number of repeat
units and, correspondingly, recognizes lengthy DNA
target sites (32,42). These TAL EBE sites are comparable
in length to, or longer than, target sites of rare-cutting
meganucleases or homing nucleases (i.e. 14–40bp) as
well as binding sites for artiﬁcial zinc ﬁnger proteins
assembled from multiple single ﬁngers (i.e. 18 or 24bp)
(5,43). All TAL effector proteins investigated thus far
exhibit high sequence speciﬁcity to the EBEs of their
target genes (32,42). The known code of TAL effectors
predicts an alignment of a single type of repeat unit to a
single nucleotide species (A, G, C or T) based on the
speciﬁc di-residues at positions 12 and 13 in the repeat
unit. This modular nature of the TAL repeat domain for
DNA-binding speciﬁcity suggests that techniques can be
developed to produce an array of repeat units that can
precisely recognize a unique, lengthy sequence of nucleo-
tides in any given gene. If so, investigators will be able to
create truly gene-speciﬁc TALNs for use in organisms with
large genomes and lacking robust systems for HR.
Thus far, several TAL effectors have been found to
function as transcription activators. Like many other
transcription factors, TAL effectors may function as
dimers to bind target DNA. However, to date, AvrBs3
is the only TAL effector shown to dimerize in vitro and
in the cytoplasm in vivo before entry into nuclei of host
cells (44). The sequence speciﬁcity of known TAL effectors
that bind DNA can be aligned to only one strand of the
target site which is usually asymmetric (28,29). Thus, it is
not yet clear if most TAL effector proteins form dimers or
multimers in the presence of target DNA (or in the
absence of DNA). The results from the present yeast
SSA assay imply that TALNs do not form homo- or
hetero-dimer at a single TAL EBE site, or at least the
dimerization of TAL subdomain does not facilitate the
dimerization of FokI nuclease domains for effective
double stranded DNA cleavage in yeast cells. More
detailed structural studies of TAL effectors or TALNs
likely will be needed to resolve this uncertainty, which
may or may not negatively inﬂuence the ability to easily
and successfully design sequence speciﬁc TALNs in the
future.
It has been established that for efﬁcient double strand
cleavage of target DNA dimerization of FokI monomer
nuclease domains is required (11). Therefore, it is conceiv-
able that TALNs need to dimerize for the efﬁcient
cleavage of DNA in solution where sufﬁcient concentra-
tions of puriﬁed proteins and substrates are present or
in vivo where TALN and target substrate are otherwise
limited. This could be achieved through various
mechanisms, three of which are presented below. In one
model, one EBE-bound TALN might form a dimer with
another bound or unbound TALN through an as yet
uncharacterized dimerization motif of TAL effector. In
such a case, the TAL subdomain-mediated dimerization
could bring the two FokI nuclease domains in close prox-
imity near the binding site and allow DNA cleavage.
Alternatively, one TALN monomer could bind to one
EBE target site and, similar to the model proposed for
the native FokI or hybrid ZFNs in vitro (13,14), dimeriza-
tion of two DNA bound-TALNs through the well
characterized dimerization motif in the FokI nuclease
subdomain could occur in close proximity and, thereby,
support DNA cleavage in trans if sufﬁcient concentrations
of nucleases were present. Successful in vitro cleavage of
DNA carrying a single AvrXa7 EBE by the FN-AvrXa7,
AvrXa7-FN and PthXo1-FN TALNs (Figure 3) is con-
sistent with this model. In a third model in which two
tandem, head-to-head or tail-to-tail EBE sites are
present, TALNs could bind to each of the EBE sites.
This would bring the two FN domains of the two
TALNs into sufﬁciently close proximity to allow dimer-
ization and DNA cleavage. Our yeast SSA data (Figure 5)
is consistent with this latter model.
The function of native FokI is allosterically regulated
through DNA and divalent metal binding. Without DNA
binding and in the absence of divalent metal, FN is se-
questered through tight interaction with the DNA recog-
nition motifs of FokI and, thus, the FokI monomer
maintains an idle state. Following binding of two FokI
holoenzymes to the FokI recognition site and in the
presence of metals, the two FokI nuclease domains are
freed and can dimerize. This dimerization then allows
Nucleic AcidsResearch, 2011, Vol.39,No. 1 369double stranded DNA cleavage (14,16,17). It is possible
that the interaction between the FN subddomain and the
TAL DNA-binding subdomain in hybrid TALN lacks
such tight regulatory mechanism and, hence nuclease
domains form dimers with less difﬁculty. That may
explain why the apparent stringency of cleavage by the
presently studied chimeric TALNs (and also ZFNs)
is lower and leads to the non-speciﬁc cleavage observed
in the presence of excess of TALNs (Supplementary
Figure S3). The structure (length and composition) of
linker segment between the DNA-binding and -cleaving
domains of FokI and its derived nucleases (i.e. ZFNs
and, likely, TALNs) also dictate the enzymes’ cleavage
pattern, for example, the distance of cleavage sites from
the DNA-binding site (45–47). The linker segment of
native FokI is 15 aa (residues 373–387) long and allows
the FN to extend and cleave the sense strand 9bp and
antisense strand 13bp downstream of the binding site
(12). An 18 aa ﬂexible linker of a ZFN accommodates
effective cleavage of target spacer in a range of 6–18bp
with 8bp as an optimum in Xenopus oocytes as
determined in a single-strand annealing reporter assay
(45). The latter study also reported that the dependence
of efﬁcient cleavage on spacer length in vitro differed from
that under in vivo condition. Because the minimum-sized
TAL effector fragment required for efﬁcient DNA binding
is unknown, the full-length AvrXa7 and PthXo1 were
used to construct the TALNs in our study. Therefore,
the N-terminal 288 aa in FN-AvrXa7 and the
C-terminal 295 aa in AvrXa7-FN and PthXo1-FN
function as long inter-domain linkers between FN and
the repeat DNA-binding domain in TALNs. Such an
extended inter-domain linker may allow signiﬁcant
‘reach’ for the nuclease domain to cut at a moderate
distance away from the ends of the EBE or allow
greater ﬂexibility for the nuclease domain to cut within a
moderately wide zone as we observed in vitro with our
TALN enzyme assays and in vivo with our yeast assays.
Future investigations will be required to determine how
various combinations of inter-domain sequence and
length affects the cleavage efﬁciency of TALNs [e.g. tests
of TALNs consisting of the FN connected directly to the
TAL effector repeat domain or through linkers of various
lengths and composition].
Other important questions are presently under active
investigation. One such question is the nature of the
DNA fragment with an apparent molecular size >10kb
when supercoiled plasmid DNA is mixed with a TALN
(lanes 4 and 7 in Figure 3B, lanes 4 and 6 in 3E). Such a
band of DNA is not observed if the supercoiled plasmid is
cleaved before mixing with the TALN (Figure 3B and E).
Our working hypothesis is that the uppermost, slow
migrating DNA band may be a complex between
plasmid DNA and the TALN protein that exists prior to
DNA cleavage (by the TALN or a restriction enzyme), but
not after cleavage. Future analyses of the component(s) of
this DNA band (i.e. ethidium bromide stained band)
should resolve this present enigma. Another issue is
TALN stability. We have observed that all of the
TALNs created for the present study have quite short
half-lives (i.e.  30–45min). This currently imposes
serious practical constraints on the degree of purity of
recombinant TALNs that can be obtained and on the
duration and extensiveness of biochemical analyses,
including accurate measurements of TALN binding
afﬁnities to DNA. Further attempts to discover conditions
that stabilize TALNs overproduced in E. coli will be im-
portant undertakings along with endeavors to determine if
such instability does or does not exist in vivo in various cell
types.
The work presented here unambiguously demonstrates
several points: the ability to fuse TAL effectors with other
proteins to create functional chimeric proteins; the speci-
ﬁcity of DNA binding by TAL effectors when fused with a
non-speciﬁc nuclease domain; and the speciﬁc cleavage of
DNA target sites by engineered TALNs both in vitro and
in vivo. The newly emerging TALN-based approach could
be an attractive alternative to the still improving
ZFN-based or meganuclease-based (48) genomic tools
for a wide variety of possible applications including
targeted genome editing. However, a few basic questions
remain unanswered regarding the feasibility of using
TALNs for genome modiﬁcation. First, can novel
TALN DNA-binding domains with the requisite speciﬁ-
city and afﬁnity be synthesized based on the actual DNA
target sequences? Although arbitrarily assembled, TAL
effectors were able to activate promoters containing
sequence elements synthesized based on the ‘code’ (29),
this capability is not yet demonstrated for a TALN
fusion protein. Second, can two different TALNs work
coordinately at preselected adjacent target sites? The
reaction involving cleavage of a dual asymmetric
PthXo1 EBE/AvrXa7 EBE site with a mixture of
PthXo1-FN and AvrXa7-FN (Figure 3E, lane 7) hints
this may be possible. That is, the two TALNs together
produced somewhat better, albeit still incomplete,
plasmid cleavage than when each TALN was used inde-
pendently at ﬁve times the concentration employed in the
dual cutting reaction—and with less non-speciﬁc plasmid
DNA cleavage (compare Figure 3E, lanes 5 and 7 with
lane 8). Third, will the DNA recognition and cleavage
by the TALNs occur in a chromosomal context in living
cells? Data from the yeast experiment described in this
paper (Figure 5) provide strong initial evidence that a
TALN or sets of TALNs can successfully ﬁnd, bind and
cleave an EBE target site within yeast chromatin.
Addressing these issues will assist in achieving the goal
of generating a tool box of TALNs for targeted genome
editing based on the DNA-binding speciﬁcity of
custom-designed, synthetic TAL repeat domains and the
DNA-cleavage function of FokI or other nucleases.
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